We are live on ! Find out more
INSP icon

Inspire Medical Systems

73.00 USD
+4.88
7.16%
At close Updated Sep 11, 4:00 PM EDT
Pre-market
After hours
73.00
0.00
0%
1 day
7.16%
5 days
19.67%
1 month
23.46%
3 months
72.01%
6 months
21.73%
Year to date
-20.88%
1 year
-11.84%
5 years
-68.9%
10 years
192.23%
 

About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

Employees: 1,333

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 39.3%
Neutral 53.6%
Negative 7.1%
Positive
Zacks Investment Research
2 days ago
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
Negative
Zacks Investment Research
11 days ago
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Neutral
GlobeNewsWire
18 days ago
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Positive
Zacks Investment Research
23 days ago
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.
INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?
Neutral
Zacks Investment Research
24 days ago
Here's Why You Should Add INSP Stock to Your Portfolio Now
Inspire Medical's Inspire V adoption, clinical evidence and underpenetrated OSA market support growth despite coding and reimbursement headwinds.
Here's Why You Should Add INSP Stock to Your Portfolio Now
Positive
Zacks Investment Research
26 days ago
New Strong Buy Stocks for August 18th
ALGT, HMC, INSP, AII and ALL have been added to the Zacks Rank #1 (Strong Buy) List on August 18, 2026.
New Strong Buy Stocks for August 18th
Positive
Zacks Investment Research
1 month ago
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist?
Positive
Zacks Investment Research
1 month ago
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
Inspire Medical raised its 2026 outlook after a Q2 beat, as Inspire V mix and cost control offset weak U.S. procedure activity.
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease
Positive
Zacks Investment Research
1 month ago
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors
Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors
Positive
Zacks Investment Research
1 month ago
Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up
INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimbursement pressures and lower revenues.
Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up
Price charts implemented using Lightweight Charts™